T-cell responses against tyrosinase 368-376(370D) peptide in HLA*A0201+ melanoma patients: randomized trial comparing incomplete Freund's adjuvant, granulocyte macrophage colony-stimulating factor, and QS-21 as immunological adjuvants.
T-cell responses against tyrosinase 368-376(370D) peptide in HLA*A0201+ melanoma patients: randomized trial comparing incomplete Freund's adjuvant, granulocyte macrophage colony-stimulating factor, and QS-21 as immunological adjuvants.
复制标题
HLA*A0201 黑色素瘤患者中针对酪氨酸酶 368-376(370D) 肽的 T 细胞反应：比较不完全弗氏佐剂、粒细胞巨噬细胞集落刺激因子和 QS-21 作为免疫佐剂的随机试验。
DOI：
--
复制
发表时间：
2002
期刊：
影响因子：
--
通讯作者：
Chapman,PaulB
中科院分区：
文献类型：
--
作者：
Schaed,SusanneG;Klimek,VirginiaM;Panageas,KatherineS;Musselli,CristinaM;Butterworth,Leah;Hwu,Wen-Jen;Livingston,PhilipO;Williams,Linda;Lewis,JonathanJ;Houghton,AlanN;Chapman,PaulB
